Korea Power Corp. (Kepco) will construct power grids in regions where renewable energy facilities are expected to be built, including the counties of Shinan and Yeonggwang in South Jeolla. Province.
Kepco has been implementing a policy since October 2016 of guaranteeing access to power grids for renewable energy facilities of 1 megawatt or smaller.
However, the concentration of 14.4 gigawatts of renewable energy facilities in specific regions resulted in power grid shortages of 4.2 gigawatts.
According to a Kepco official, the state-run utility will address the shortage of 3.2 gigawatts by next year.
It would further solve the shortage of 1 gigawatt by shortening the construction period of substations from six years to three years and increasing grid access limits from 10 megawatts to 12 megawatts.
Kepco will also apply different calculation methods when allocating grids.
According to Kepco, as renewable energy facilities rarely utilize 100 percent of the grid capacity, it will now only assign 70 percent capacity.
In its example, Kepco said that 10-megawatt solar farms would only be allocated a grid capacity of 7 megawatts as seldom reach maximum power output.


SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Standard Chartered Expands Hedge Fund Access for Wealth Clients
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Shein Targets $26B-$27B Valuation for Hong Kong IPO
OpenAI Tightens AI Safety Monitoring After Security Incidents
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
SK Hynix Shares Surge on Record $28.6 Billion Buyback
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



